Hu Xulin, Wu Haoming, Yong Xin, Wang Yao, Yang Shuhao, Fan Diyi, Xiao Yibo, Che Lanyu, Shi Kun, Li Kainan, Xiong Chengdong, Zhu Huili, Qian Zhiyong
Clinical Medical College and Affiliated Hospital of Chengdu University Chengdu University Chengdu Sichuan China.
Department of Biotherapy Cancer Center and State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.
MedComm (2020). 2023 Dec 1;4(6):e425. doi: 10.1002/mco2.425. eCollection 2023 Dec.
The endometrium is a unique human tissue with an extraordinary ability to undergo a hormone-regulated cycle encompassing shedding, bleeding, scarless repair, and regeneration throughout the female reproductive cycle. The cyclical repair and regeneration of the endometrium manifest as changes in endometrial epithelialization, glandular regeneration, and vascularization. The mechanisms encompass inflammation, coagulation, and fibrinolytic system balance. However, specific conditions such as endometriosis or TCRA treatment can disrupt the process of cyclical endometrial repair and regeneration. There is uncertainty about traditional clinical treatments' efficacy and side effects, and finding new therapeutic interventions is essential. Researchers have made substantial progress in the perspective of regenerative medicine toward maintaining cyclical endometrial repair and regeneration in recent years. Such progress encompasses the integration of biomaterials, tissue-engineered scaffolds, stem cell therapies, and 3D printing. This review analyzes the mechanisms, diseases, and interventions associated with cyclical endometrial repair and regeneration. The review discusses the advantages and disadvantages of the regenerative interventions currently employed in clinical practice. Additionally, it highlights the significant advantages of regenerative medicine in this domain. Finally, we review stem cells and biologics among the available interventions in regenerative medicine, providing insights into future therapeutic strategies.
子宫内膜是一种独特的人体组织,具有非凡的能力,能够在整个女性生殖周期经历由激素调节的循环,包括脱落、出血、无瘢痕修复和再生。子宫内膜的周期性修复和再生表现为子宫内膜上皮化、腺体再生和血管生成的变化。其机制包括炎症、凝血和纤维蛋白溶解系统平衡。然而,诸如子宫内膜异位症或TCRA治疗等特定情况会扰乱子宫内膜周期性修复和再生的过程。传统临床治疗的疗效和副作用存在不确定性,因此寻找新的治疗干预措施至关重要。近年来,研究人员在再生医学领域,在维持子宫内膜周期性修复和再生方面取得了重大进展。这些进展包括生物材料、组织工程支架、干细胞疗法和3D打印的整合。本综述分析了与子宫内膜周期性修复和再生相关的机制、疾病和干预措施。该综述讨论了目前临床实践中采用的再生干预措施的优缺点。此外,它还强调了再生医学在这一领域的显著优势。最后,我们回顾了再生医学现有干预措施中的干细胞和生物制品,为未来的治疗策略提供见解。